Tracking the Investment in Cancer Research: 2005 to 2019
Today, the CCRA released its latest report on the investment in cancer research from 2005 to 2019. A grand total of $7.4 billion was invested during this 15-year period. The fluctuating investment in major infrastructure drove peaks and valleys in the overall investment trend. Cancer researchers, however, retained their competitiveness. In recent years, Canada lost ground in terms of its cancer research investment when compared with the U.K. and the U.S. This report has an accompanying Excel file as well as dashboard tools that expand on the findings in the report. To access this report, click here.

The Canadian Cancer Clinical Trials Network (3CTN) and its collaborative partners are thrilled to announce the launch of an Equity, Diversity, and Inclusion (EDI) Framework and companion Toolkit designed to support the Canadian research community in embedding EDI best practices within clinical tri...
CCRA released its latest reports on the investment in cancer research. In addition to the overview report, there are brief reports on the research investments made in childhood and adolescent cancers, cancer risk and prevention, cancer survivorship, palliative and end-of-life cancer care and translational research. Reports are av...